The CDC Proposes DoxyPep as a “Morning After Pill” for Some STIs

Taking doxycycline after sex has been shown to be effective in preventing transmission of some bacterial STIs.

The Centers for Disease Control is set to recommend the usage of a common antibiotic as a “morning after pill for STIs,” for men who have sex with men and trans women, in a move that could help curb the U.S.’s STI epidemic.

Doxycycline is an antibiotic that has been shown to be highly effective in preventing the transmission of gonorrhea, chlamydia, and syphilis if a dose of 200 mg is taken up to 72 hours after having condomless sex. Because it is a form of post-exposure prophylaxis (PEP), doxycycline when used in this way is referred to as DoxyPEP.

The CDC is developing draft guidelines that would act as a resource for providers in prescribing DoxyPEP for STI prevention, which the agency released Monday. The recommendations, which provide clinical guidance for the usage of DoxyPEP, are open for public comment for 45 days, and a final version is expected to be published early next year, per CBS News.

R&I – TP